ARS Pharmaceuticals, Inc. (SPRY) Revenue History
ARS Pharmaceuticals, Inc. (SPRY) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $5.51M |
| 2022-12-31 | $1.32M |
| 2023-12-31 | $30.00K |
| 2024-12-31 | $89.15M |
| 2025-12-31 | $84.28M |
How SPRY compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| HBIO | Harvard Bioscience Inc. | $86.55M |
| ETON | Eton Pharmaceuticals Inc. | $79.95M |
| RMTI | Rockwell Medical Inc. | $69.26M |
| NTLA | Intellia Therapeutics Inc. | $67.67M |
| KURA | Kura Oncology Inc. | $67.48M |
These are five companies in the same sector as SPRY with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get ARS Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("SPRY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRY | $5.95 | +0.68% | 1.35M |
| 3 | ||||
| 4 | ||||
| 5 |